These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3094063)

  • 1. Desamino-D-arg8-vasopressin (DDAVP), unlike ethanol, has no effect on a boring visual vigilance task in humans.
    Sahgal A; Wright C; Ferrier IN
    Psychopharmacology (Berl); 1986; 90(1):58-63. PubMed ID: 3094063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin peptide (DDAVP) may narrow the focus of attention in normal elderly.
    Jennings JR; Nebes RD; Reynolds CF
    Psychiatry Res; 1986 Jan; 17(1):31-9. PubMed ID: 3945698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-aldosterone axis in ethanol intoxication: effect of an ADH analogue (desaminocys1-D-arg8-vasopressin, DDAVP).
    Nieminen MM; Linkola J; Soveri P; Fyhrquist F
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):558-62. PubMed ID: 6360918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No improvement in ethanol-induced memory deficits after administration of a vasopressin analog.
    Eisenhofer G; Lambie DG; Robinson BJ
    Life Sci; 1985 Dec; 37(26):2499-505. PubMed ID: 4079660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin analogue (DDAVP) facilitates recall of narrative prose.
    Beckwith BE; Petros TV; Bergloff PJ; Staebler RJ
    Behav Neurosci; 1987 Jun; 101(3):429-32. PubMed ID: 3606814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of posttrial administration of vasopressin analogue (DDAVP) to influence memory in healthy, young, male volunteers.
    Beckwith BE; Petros TV; Bergloff PJ; Swenson RR; Paulson R
    Peptides; 1995; 16(8):1327-8. PubMed ID: 8745039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal absorption and plasma clearance rates of [D-Arg8]vasopressin analogues in the rat.
    Lundin S; Folkesson HG; Pierzynovski SG; Bengtsson HI
    Peptides; 1994; 15(5):809-14. PubMed ID: 7984498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of human atrial natriuretic peptide on 1-deamino-D-Arg8-vasopressin-induced antidiuresis in man.
    Vierhapper H; Nowotny P; Waldhäusl W
    J Clin Endocrinol Metab; 1988 Jan; 66(1):124-7. PubMed ID: 2961782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin analog influences the performance of males on a reaction time task.
    Beckwith BE; Couk DI; Till TS
    Peptides; 1983; 4(5):707-9. PubMed ID: 6657514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
    Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in a simple test of renal concentrating ability].
    Tuschy U; Szeszat S; Rindfleisch U
    Z Gesamte Inn Med; 1984 Jun; 39(11):265-8. PubMed ID: 6475171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor.
    Saito M; Tahara A; Sugimoto T
    Biochem Pharmacol; 1997 Jun; 53(11):1711-7. PubMed ID: 9264324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1-desamino-D-arginine vasopressin, ACTH 4-10 and adrenaline on acquisition of active avoidance response in prenatally ethanol-treated rats.
    Markel E; Korányi L; Lévay G; Sciaccianoce S; Endröczi E
    Exp Clin Endocrinol; 1987 Aug; 90(1):9-16. PubMed ID: 2822454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of [3H]1-desamino-8-D-arginine vasopressin as a radioligand for vasopressin V2-receptors in rat kidney.
    Marchingo AJ; Abrahams JM; Woodcock EA; Smith AI; Mendelsohn FA; Johnston CI
    Endocrinology; 1988 Apr; 122(4):1328-36. PubMed ID: 2964362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flushing and haemodynamic responses to vasopressin peptides in the rhesus monkey.
    Brooks DP; Koster PF; Stassen FL; Albrightson CR; Huffman WF; Wasserman MA; Kinter LB
    Br J Pharmacol; 1988 Jul; 94(3):759-64. PubMed ID: 3179611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desensitization of rat renal thick ascending limb cells to vasopressin.
    Elalouf JM; Sari DC; Roinel N; de Rouffignac C
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2407-11. PubMed ID: 3353389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between a synthetic analogue of vasopressin and human peripheral blood lymphocytes.
    Wickramasinghe SN; Valdimarsson H; Williams B
    J Clin Lab Immunol; 1982 Jan; 7(1):67-70. PubMed ID: 6279851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
    N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of DDAVP, a vasopressin analog, on delayed matching behavior in the pigeon.
    Teal JJ; Evans HL
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1123-7. PubMed ID: 7163345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of DDAVP on renal hemodynamics and renin secretion in subjects with essential hypertension.
    Brink HS; Derkx FH; Boomsma F; Schalekamp MA
    Clin Nephrol; 1994 Aug; 42(2):95-101. PubMed ID: 7955585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.